{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T04:20:07Z","timestamp":1783398007319,"version":"3.54.6"},"reference-count":190,"publisher":"Oxford University Press (OUP)","license":[{"start":{"date-parts":[[2024,7,24]],"date-time":"2024-07-24T00:00:00Z","timestamp":1721779200000},"content-version":"vor","delay-in-days":205,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,2,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Chlamydia trachomatis is the most prevalent bacterial sexually transmitted infection globally. Antibiotic treatment is highly effective, but infection is often asymptomatic resulting in most individuals going undetected and untreated. This untreated infection can ascend to the upper female genital tract to cause pelvic inflammatory disease, tubal factor infertility, and ectopic pregnancy. Chlamydia screening and treatment programs have failed to control this epidemic and demonstrate the need for an efficacious vaccine to prevent transmission and disease. Animal models and human epidemiological data reveal that natural immunity can provide partial or short-lived sterilizing immunity. These data further demonstrate the importance of eliciting interferon gamma (IFN\u03b3)-producing cluster of differentiation 4 (CD4) T cells (Th1 and Th1\/17 cells) that can likely synergize with antibody-mediated opsonophagocytosis to provide optimal protection. These studies have guided preclinical rational vaccine design for decades and the first Phase 1 clinical trials have recently been completed. Recent advances have led to improvements in vaccine platforms and clinically safe adjuvants that help provide a path forward. This review describes vaccine models, correlates of immunity, antigen and adjuvant selection, and future clinical testing for Chlamydia vaccine development.<\/jats:p>","DOI":"10.1093\/femspd\/ftae017","type":"journal-article","created":{"date-parts":[[2024,7,25]],"date-time":"2024-07-25T00:08:12Z","timestamp":1721866092000},"source":"Crossref","is-referenced-by-count":14,"title":["Advances in vaccine development for <i>Chlamydia trachomatis<\/i>"],"prefix":"10.1093","volume":"82","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5985-4153","authenticated-orcid":false,"given":"Taylor B","family":"Poston","sequence":"first","affiliation":[{"name":"Department of Pediatrics, University of North Carolina at Chapel Hill , Chapel Hill, NC 27599 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,7,23]]},"reference":[{"key":"2024121400015953900_bib1","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/S1473-3099(19)30279-8","article-title":"Safety and immunogenicity of the Chlamydia vaccine candidate CTH522 adjuvanted with CAF01 liposomes or aluminium hydroxide a first-in-human, randomised, double-blind, placebo-controlled, phase 1 trial","volume":"19","author":"Abraham","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"2024121400015953900_bib2","doi-asserted-by":"crossref","first-page":"e3116","DOI":"10.1371\/journal.pone.0003116","article-title":"Cationic liposomes formulated with synthetic mycobacterial cordfactor (CAF01) a versatile adjuvant for vaccines with different immunological requirements","volume":"3","author":"Agger","year":"2008","journal-title":"PLoS One"},{"key":"2024121400015953900_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s12276-019-0333-0","article-title":"STING signaling and host defense against microbial infection","volume":"51","author":"Ahn","year":"2019","journal-title":"Exp Mol Med"},{"key":"2024121400015953900_bib4","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1080\/21645515.2020.1829899","article-title":"A phase 1, randomized, placebo-controlled study to evaluate the safety and immunogenicity of an mRNA-based RSV prefusion F protein vaccine in healthy younger and older adults","volume":"17","author":"Aliprantis","year":"2021","journal-title":"Hum Vaccin Immunother"},{"key":"2024121400015953900_bib5","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1038\/s41385-018-0080-x","article-title":"Sustained protective immunity against Bordetella pertussis nasal colonization by intranasal immunization with a vaccine-adjuvant combination that induces IL-17-secreting T(RM) cells","volume":"11","author":"Allen","year":"2018","journal-title":"Mucosal Immunol"},{"key":"2024121400015953900_bib6","doi-asserted-by":"crossref","first-page":"50","DOI":"10.4161\/auto.22482","article-title":"Autophagy restricts Chlamydia trachomatis growth in human macrophages via IFNG-inducible guanylate binding proteins","volume":"9","author":"Al-Zeer","year":"2013","journal-title":"Autophagy"},{"key":"2024121400015953900_bib7","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines8030353","article-title":"Mucosal vaccination with UV-inactivated Chlamydia suis in pre-exposed outbred pigs decreases pathogen load and induces CD4 T-cell maturation into IFN-gamma(+) effector memory cells","volume-title":"Vaccines (Basel)","author":"Amaral","year":"2020"},{"key":"2024121400015953900_bib8","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1016\/j.cell.2019.07.032","article-title":"Effector T(H)17 cells give rise to long-lived T(RM) cells that are essential for an immediate response against bacterial infection","volume":"178","author":"Amezcua\u00a0Vesely","year":"2019","journal-title":"Cell"},{"key":"2024121400015953900_bib9","doi-asserted-by":"crossref","first-page":"e13331","DOI":"10.1111\/sji.13331","article-title":"IgG exacerbates genital chlamydial pathology in females by enhancing pathogenic CD8(+) T cell responses","volume":"99","author":"Armitage","year":"2024","journal-title":"Scand J Immunol"},{"key":"2024121400015953900_bib10","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJMoa2035389","article-title":"Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine","volume":"384","author":"Baden","year":"2021","journal-title":"N Engl J Med"},{"key":"2024121400015953900_bib11","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1086\/652400","article-title":"Protective immunity to Chlamydia trachomatis genital infection evidence from human studies","volume":"201","author":"Batteiger","year":"2010","journal-title":"J Infect Dis"},{"key":"2024121400015953900_bib12","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1016\/S0140-6736(07)60367-5","article-title":"Global perspectives on the sexual and reproductive health of adolescents patterns, prevention, and potential","volume":"369","author":"Bearinger","year":"2007","journal-title":"Lancet North Am Ed"},{"key":"2024121400015953900_bib13","doi-asserted-by":"crossref","first-page":"3998","DOI":"10.1073\/pnas.90.9.3998","article-title":"Morphologic and antigenic characterization of interferon gamma-mediated persistent Chlamydia trachomatis infection in vitro","volume":"90","author":"Beatty","year":"1993","journal-title":"P Natl Acad Sci U S A"},{"key":"2024121400015953900_bib14","doi-asserted-by":"crossref","first-page":"14092","DOI":"10.1073\/pnas.0603338103","article-title":"The p47 GTPases igtp and Irgb10 map to the Chlamydia trachomatis susceptibility locus Ctrq-3 and mediate cellular resistance in mice","volume":"103","author":"Bernstein-Hanley","year":"2006","journal-title":"P Natl Acad Sci U S A"},{"key":"2024121400015953900_bib15","doi-asserted-by":"crossref","first-page":"113803","DOI":"10.1016\/j.addr.2021.05.013","article-title":"Evolution of toll-like receptor 7\/8 agonist therapeutics and their delivery approaches from antiviral formulations to vaccine adjuvants","volume":"175","author":"Bhagchandani","year":"2021","journal-title":"Adv Drug Deliv Rev"},{"key":"2024121400015953900_bib16","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.vaccine.2011.10.086","article-title":"Comparison of immune responses and protective efficacy of intranasal prime-boost immunization regimens using adenovirus-based and CpG\/HH2 adjuvanted-subunit vaccines against genital Chlamydia muridarum infection","volume":"30","author":"Brown","year":"2012","journal-title":"Vaccine"},{"key":"2024121400015953900_bib17","doi-asserted-by":"crossref","first-page":"e13286","DOI":"10.1111\/aji.13286","article-title":"Testicular inflammation and infertility could chlamydial infections be contributing?","volume":"84","author":"Bryan","year":"2020","journal-title":"American J Rep Immunol"},{"key":"2024121400015953900_bib18","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1093\/biolre\/ioz229","article-title":"Chronic testicular Chlamydia muridarum infection impairs mouse fertility and offspring developmentdagger","volume":"102","author":"Bryan","year":"2020","journal-title":"Biol Reprod"},{"key":"2024121400015953900_bib19","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1093\/biolre\/ioad021","article-title":"Prophylactic and therapeutic vaccination protects sperm health from Chlamydia muridarum-induced abnormalities","volume":"108","author":"Bryan","year":"2023","journal-title":"Biol Reprod"},{"key":"2024121400015953900_bib20","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1089\/jir.1986.6.389","article-title":"Induction of tryptophan degradation in vitro and in vivo a gamma-interferon-stimulated activity","volume":"6","author":"Byrne","year":"1986","journal-title":"J Interferon Res"},{"key":"2024121400015953900_bib21","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.immuni.2016.02.004","article-title":"The vaccine adjuvant Chitosan promotes cellular immunity via DNA sensor cGAS-STING-dependent induction of type I interferons","volume":"44","author":"Carroll","year":"2016","journal-title":"Immunity"},{"key":"2024121400015953900_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2016\/5758387","article-title":"Extragenital infections caused by Chlamydia trachomatis and Neisseria gonorrhoeae a review of the literature","volume":"2016","author":"Chan","year":"2016","journal-title":"Infect Dis Obstet Gynecol"},{"key":"2024121400015953900_bib23","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1128\/IAI.03158-14","article-title":"In vitro passage selects for Chlamydia muridarum with enhanced infectivity in cultured cells but attenuated pathogenicity in mouse upper genital tract","volume":"83","author":"Chen","year":"2015","journal-title":"Infect Immun"},{"key":"2024121400015953900_bib24","doi-asserted-by":"crossref","first-page":"e252","DOI":"10.1016\/S2666-5247(22)00027-1","article-title":"Safety and immunogenicity of a synthetic multiantigen modified vaccinia virus Ankara-based COVID-19 vaccine (COH04S1) an open-label and randomised, phase 1 trial","volume":"3","author":"Chiuppesi","year":"2022","journal-title":"Lancet Microbe"},{"key":"2024121400015953900_bib25","doi-asserted-by":"crossref","first-page":"4933","DOI":"10.1021\/acs.molpharmaceut.8b00579","article-title":"Acetalated dextran microparticles for codelivery of STING and TLR7\/8 agonists","volume":"15","author":"Collier","year":"2018","journal-title":"Mol Pharmaceutics"},{"key":"2024121400015953900_bib26","doi-asserted-by":"crossref","first-page":"3773","DOI":"10.1016\/j.vaccine.2007.02.010","article-title":"Intranasal immunization with chlamydial protease-like activity factor and CpG deoxynucleotides enhances protective immunity against genital Chlamydia muridarum infection","volume":"25","author":"Cong","year":"2007","journal-title":"Vaccine"},{"key":"2024121400015953900_bib27","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1128\/IAI.01171-15","article-title":"The chromosome-encoded hypothetical protein TC0668 is an upper genital tract pathogenicity factor of Chlamydia muridarum","volume":"84","author":"Conrad","year":"2016","journal-title":"Infect Immun"},{"key":"2024121400015953900_bib28","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1016\/j.celrep.2015.04.031","article-title":"Direct activation of STING in the tumor microenvironment leads to potent and systemic tumor regression and immunity","volume":"11","author":"Corrales","year":"2015","journal-title":"Cell Rep"},{"key":"2024121400015953900_bib29","doi-asserted-by":"crossref","first-page":"3481","DOI":"10.1016\/j.vaccine.2023.04.063","article-title":"Endotoxin contamination of nanoparticle formulations a concern in vaccine adjuvant mechanistic studies","volume":"41","author":"Costa","year":"2023","journal-title":"Vaccine"},{"key":"2024121400015953900_bib30","doi-asserted-by":"crossref","first-page":"4861","DOI":"10.1016\/j.vaccine.2010.05.050","article-title":"CD4+ T cells reduce the tissue burden of Chlamydia muridarum in male BALB\/c mice","volume":"28","author":"Cunningham","year":"2010","journal-title":"Vaccine"},{"key":"2024121400015953900_bib31","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.ebiom.2017.03.045","article-title":"Dose-dependent T-cell dynamics and cytokine cascade following rVSV-ZEBOV immunization","volume":"19","author":"Dahlke","year":"2017","journal-title":"EBioMedicine"},{"key":"2024121400015953900_bib32","doi-asserted-by":"crossref","first-page":"e13103","DOI":"10.1111\/aji.13103","article-title":"Anti-Chlamydia IgG and IgA are insufficient to prevent endometrial Chlamydia infection in women, and increased anti-Chlamydia IgG is associated with enhanced risk for incident infection","volume":"81","author":"Darville","year":"2019","journal-title":"Am J Rep Immunol"},{"key":"2024121400015953900_bib33","doi-asserted-by":"crossref","first-page":"S39","DOI":"10.1093\/infdis\/jiab031","article-title":"Pelvic inflammatory disease due to Neisseria gonorrhoeae and Chlamydia trachomatis immune evasion mechanisms and pathogenic disease pathways","volume":"224","author":"Darville","year":"2021","journal-title":"J Infect Dis"},{"key":"2024121400015953900_bib34","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1093\/cid\/ciy1087","article-title":"Controlled Human malaria infection of healthy adults with lifelong malaria exposure to assess safety, immunogenicity, and efficacy of the asexual blood stage malaria vaccine candidate GMZ2","volume":"69","author":"Dejon-Agobe","year":"2019","journal-title":"Clin Infect Dis"},{"key":"2024121400015953900_bib35","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1080\/14760584.2021.1899817","article-title":"Chlamydia trachomatis vaccines for genital infections where are we and how far is there to go?","volume":"20","author":"de\u00a0la\u00a0Maza","year":"2021","journal-title":"Expert Rev Vaccines"},{"key":"2024121400015953900_bib36","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/0264-410X(95)80022-6","article-title":"A new computer model for estimating the impact of vaccination protocols and its application to the study of Chlamydia trachomatis genital infections","volume":"13","author":"de\u00a0la\u00a0Maza","year":"1995","journal-title":"Vaccine"},{"key":"2024121400015953900_bib37","doi-asserted-by":"crossref","first-page":"e53531","DOI":"10.1371\/journal.pone.0053531","article-title":"The mincle-activating adjuvant TDB induces MyD88-dependent Th1 and Th17 responses through IL-1R signaling","volume":"8","author":"Desel","year":"2013","journal-title":"PLoS One"},{"key":"2024121400015953900_bib38","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1093\/infdis\/jiy214","article-title":"Induction of cross-clade antibody and T-cell responses by a modified Vaccinia virus Ankara-based Influenza A(H5N1) vaccine in a randomized phase 1\/2a clinical trial","volume":"218","author":"de\u00a0Vries","year":"2018","journal-title":"J Infect Dis"},{"key":"2024121400015953900_bib39","doi-asserted-by":"crossref","first-page":"5210","DOI":"10.1016\/j.vaccine.2011.05.026","article-title":"Bis-(3',5')-cyclic dimeric adenosine monophosphate strong Th1\/Th2\/Th17 promoting mucosal adjuvant","volume":"29","author":"Ebensen","year":"2011","journal-title":"Vaccine"},{"key":"2024121400015953900_bib40","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/S1473-3099(22)00764-2","article-title":"The safety and immunogenicity of two Zika virus mRNA vaccine candidates in healthy flavivirus baseline seropositive and seronegative adults the results of two randomised, placebo-controlled, dose-ranging, phase 1 clinical trials","volume":"23","author":"Essink","year":"2023","journal-title":"Lancet Infect Dis"},{"key":"2024121400015953900_bib41","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41591-020-01194-5","article-title":"Oxford CVTG t cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1\/2 clinical trial","volume":"27","author":"Ewer","year":"2021","journal-title":"Nat Med"},{"key":"2024121400015953900_bib42","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/S0091-7435(02)00058-0","article-title":"Asymptomatic sexually transmitted diseases the case for screening","volume":"36","author":"Farley","year":"2003","journal-title":"Prev Med"},{"key":"2024121400015953900_bib43","doi-asserted-by":"crossref","first-page":"4374","DOI":"10.1128\/IAI.00622-10","article-title":"CD4+ T cells and antibody are required for optimal major outer membrane protein vaccine-induced immunity to Chlamydia muridarum genital infection","volume":"78","author":"Farris","year":"2010","journal-title":"Infect Immun"},{"key":"2024121400015953900_bib44","doi-asserted-by":"crossref","first-page":"26893","DOI":"10.1074\/jbc.M203937200","article-title":"Molecular basis defining human Chlamydia trachomatis tissue tropism. A possible role for tryptophan synthase","volume":"277","author":"Fehlner-Gardiner","year":"2002","journal-title":"J Biol Chem"},{"key":"2024121400015953900_bib45","doi-asserted-by":"crossref","first-page":"3326","DOI":"10.1016\/j.vaccine.2019.04.074","article-title":"mRNA vaccines against H10N8 and H7N9 influenza viruses of pandemic potential are immunogenic and well tolerated in healthy adults in phase 1 randomized clinical trials","volume":"37","author":"Feldman","year":"2019","journal-title":"Vaccine"},{"key":"2024121400015953900_bib46","doi-asserted-by":"crossref","first-page":"9969","DOI":"10.1073\/pnas.1101756108","article-title":"Approach to discover T- and B-cell antigens of intracellular pathogens applied to the design of Chlamydia trachomatis vaccines","volume":"108","author":"Finco","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2024121400015953900_bib47","doi-asserted-by":"crossref","first-page":"4740","DOI":"10.1128\/IAI.00856-15","article-title":"Guanylate binding proteins enable rapid activation of canonical and noncanonical inflammasomes in Chlamydia-infected macrophages","volume":"83","author":"Finethy","year":"2015","journal-title":"Infect Immun"},{"key":"2024121400015953900_bib48","doi-asserted-by":"crossref","first-page":"S112","DOI":"10.1093\/cid\/ciac126","article-title":"Diagnosis and management of uncomplicated Chlamydia trachomatis infections in adolescents and adults summary of evidence reviewed for the 2021 Centers for Disease Control and Prevention Sexually transmitted Infections Treatment Guidelines","volume":"74","author":"Geisler","year":"2022","journal-title":"Clin Infect Dis"},{"key":"2024121400015953900_bib49","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1093\/infdis\/jit094","article-title":"3rd spontaneous resolution of genital Chlamydia trachomatis infection in women and protection from reinfection","volume":"207","author":"Geisler","year":"2013","journal-title":"J Infect Dis"},{"key":"2024121400015953900_bib50","doi-asserted-by":"crossref","first-page":"e00385","DOI":"10.1128\/mBio.00385-19","article-title":"Genetic screen in Chlamydia muridarum reveals role for an interferon-induced host cell death program in antimicrobial inclusion rupture","volume":"10","author":"Giebel","year":"2019","journal-title":"mBio"},{"key":"2024121400015953900_bib51","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.cellimm.2012.07.006","article-title":"Evidence for cyclic diguanylate as a vaccine adjuvant with novel immunostimulatory activities","volume":"278","author":"Gray","year":"2012","journal-title":"Cell Immunol"},{"key":"2024121400015953900_bib52","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1086\/598983","article-title":"Modeling the impact of potential vaccines on epidemics of sexually transmitted Chlamydia trachomatis infection","volume":"199","author":"Gray","year":"2009","journal-title":"J Infect Dis"},{"key":"2024121400015953900_bib53","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/00007435-197804000-00011","article-title":"The potential for vaccine against infection of the genital tract with Chlamydia trachomatis","volume":"5","author":"Grayston","year":"1978","journal-title":"Sex Transm Dis"},{"key":"2024121400015953900_bib54","doi-asserted-by":"crossref","first-page":"589","DOI":"10.3181\/00379727-112-28112","article-title":"Field studies of protection from infection by experimental trachoma virus vaccine in preschool-aged children on Taiwan","volume":"112","author":"Grayston","year":"1963","journal-title":"Exp Biol Med"},{"key":"2024121400015953900_bib55","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1086\/652395","article-title":"Risk of sequelae after Chlamydia trachomatis genital infection in women","volume":"201","author":"Haggerty","year":"2010","journal-title":"J Infect Dis"},{"key":"2024121400015953900_bib56","doi-asserted-by":"crossref","first-page":"e1738","DOI":"10.1002\/wnan.1738","article-title":"Endotoxin contamination of engineered nanomaterials overcoming the hurdles associated with endotoxin testing","volume":"13","author":"Hannon","year":"2021","journal-title":"WIREs Nanomed Nanobiotechnol"},{"key":"2024121400015953900_bib57","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1086\/590670","article-title":"Liposome delivery of Chlamydia muridarum major outer membrane protein primes a Th1 response that protects against genital chlamydial infection in a mouse model","volume":"198","author":"Hansen","year":"2008","journal-title":"J Infect Dis"},{"key":"2024121400015953900_bib58","doi-asserted-by":"crossref","first-page":"eabn1413","DOI":"10.1126\/scitranslmed.abn1413","article-title":"Intranasal vaccination with lipid-conjugated immunogens promotes antigen transmucosal uptake to drive mucosal and systemic immunity","volume":"14","author":"Hartwell","year":"2022","journal-title":"Sci Transl Med"},{"key":"2024121400015953900_bib59","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/j.1365-2567.2007.02608.x","article-title":"Live-attenuated influenza viruses as delivery vectors for Chlamydia vaccines","volume":"122","author":"He","year":"2007","journal-title":"Immunology"},{"key":"2024121400015953900_bib60","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1016\/j.vaccine.2009.12.010","article-title":"Oral immunization with a novel lipid-based adjuvant protects against genital Chlamydia infection","volume":"28","author":"Hickey","year":"2010","journal-title":"Vaccine"},{"key":"2024121400015953900_bib61","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1111\/imm.13382","article-title":"Distinct antigen uptake receptors route to the same storage compartments for cross-presentation in dendritic cells","volume":"164","author":"Ho","year":"2021","journal-title":"Immunology"},{"key":"2024121400015953900_bib62","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1038\/nm1213","article-title":"Mucosal immunity and vaccines","volume":"11","author":"Holmgren","year":"2005","journal-title":"Nat Med"},{"key":"2024121400015953900_bib63","doi-asserted-by":"crossref","first-page":"3456","DOI":"10.1016\/j.apsb.2022.07.002","article-title":"Mucosal vaccine delivery a focus on the breakthrough of specific barriers","volume":"12","author":"Huang","year":"2022","journal-title":"Acta Pharmaceutica Sinica B"},{"key":"2024121400015953900_bib64","doi-asserted-by":"crossref","first-page":"e0124840","DOI":"10.1371\/journal.pone.0124840","article-title":"Plasmid-encoded Pgp5 is a significant contributor to Chlamydia muridarum induction of Hydrosalpinx","volume":"10","author":"Huang","year":"2015","journal-title":"PLoS One"},{"key":"2024121400015953900_bib65","doi-asserted-by":"crossref","first-page":"eabi9002","DOI":"10.1126\/sciimmunol.abi9002","article-title":"A diamidobenzimidazole STING agonist protects against SARS-CoV-2 infection","volume":"6","author":"Humphries","year":"2021","journal-title":"Sci Immunol"},{"key":"2024121400015953900_bib66","doi-asserted-by":"crossref","first-page":"5195","DOI":"10.1128\/iai.62.11.5195-5197.1994","article-title":"Role for CD8+ T cells in antichlamydial immunity defined by Chlamydia-specific T-lymphocyte clones","volume":"62","author":"Igietseme","year":"1994","journal-title":"Infect Immun"},{"key":"2024121400015953900_bib67","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.1021\/acs.bioconjchem.0c00523","article-title":"Immune responses and antitumor effect through delivering to antigen presenting cells by optimized conjugates consisting of CpG-DNA and antigenic peptide","volume":"31","author":"Irie","year":"2020","journal-title":"Bioconjug Chem"},{"key":"2024121400015953900_bib68","doi-asserted-by":"crossref","first-page":"6911","DOI":"10.4049\/jimmunol.1002596","article-title":"Chlamydia-specific CD4 T cell clones control Chlamydia muridarum replication in epithelial cells by nitric oxide-dependent and -independent mechanisms","volume":"185","author":"Jayarapu","year":"2010","journal-title":"J Immunol"},{"key":"2024121400015953900_bib69","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.4049\/jimmunol.1102764","article-title":"Plac8-dependent and inducible NO synthase-dependent mechanisms clear Chlamydia muridarum infections from the genital tract","volume":"188","author":"Johnson","year":"2012","journal-title":"J Immunol"},{"key":"2024121400015953900_bib70","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1084\/jem.20111266","article-title":"A live-attenuated chlamydial vaccine protects against trachoma in nonhuman primates","volume":"208","author":"Kari","year":"2011","journal-title":"J Exp Med"},{"key":"2024121400015953900_bib71","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1172\/JCI45416","article-title":"Protective T cell immunity in mice following protein-TLR7\/8 agonist-conjugate immunization requires aggregation, type I IFN, and multiple DC subsets","volume":"121","author":"Kastenmuller","year":"2011","journal-title":"J Clin Invest"},{"key":"2024121400015953900_bib72","doi-asserted-by":"crossref","first-page":"eabq4120","DOI":"10.1126\/sciadv.abq4120","article-title":"A sublingual nanofiber vaccine to prevent urinary tract infections","volume":"8","author":"Kelly","year":"2022","journal-title":"Sci Adv"},{"key":"2024121400015953900_bib73","doi-asserted-by":"crossref","first-page":"e223","DOI":"10.1097\/OLQ.0000000000001549","article-title":"Rectal Chlamydia trachomatis infection a narrative review of the State of the science and research priorities","volume":"48","author":"Khosropour","year":"2021","journal-title":"Sexual Trans Dis"},{"key":"2024121400015953900_bib74","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1093\/infdis\/173.6.1437","article-title":"Risk factors for Chlamydia trachomatis pelvic inflammatory disease among sex workers in Nairobi, Kenya","volume":"173","author":"Kimani","year":"1996","journal-title":"J Infect Dis"},{"key":"2024121400015953900_bib75","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.jconrel.2020.09.040","article-title":"Dual-adjuvant effect of pH-sensitive liposomes loaded with STING and TLR9 agonists regress tumor development by enhancing Th1 immune response","volume":"328","author":"Kocabas","year":"2020","journal-title":"J Controlled Release"},{"key":"2024121400015953900_bib76","doi-asserted-by":"crossref","first-page":"eadg1036","DOI":"10.1126\/sciadv.adg1036","article-title":"A single-dose F1-based mRNA-LNP vaccine provides protection against the lethal plague bacterium","volume":"9","author":"Kon","year":"2023","journal-title":"Sci Adv"},{"key":"2024121400015953900_bib77","first-page":"e145228","article-title":"Intranasal immunization with peptide-based immunogenic complex enhances BCG vaccine efficacy in a murine model of tuberculosis","volume":"6","author":"Kumar","year":"2021","journal-title":"JCI Insight"},{"key":"2024121400015953900_bib78","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/978-1-4939-6445-1_11","article-title":"Preparing an adjuvanted thermoresponsive gel formulation for sublingual vaccination","volume":"1494","author":"Lal","year":"2017","journal-title":"Methods Mol Biol"},{"key":"2024121400015953900_bib79","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1038\/s41577-021-00583-2","article-title":"Mucosal vaccines\u2014fortifying the frontiers","volume":"22","author":"Lavelle","year":"2022","journal-title":"Nat Rev Immunol"},{"key":"2024121400015953900_bib80","doi-asserted-by":"crossref","first-page":"5105","DOI":"10.1128\/IAI.00668-07","article-title":"Severe tryptophan starvation blocks onset of conventional persistence and reduces reactivation of Chlamydia trachomatis","volume":"75","author":"Leonhardt","year":"2007","journal-title":"Infect Immun"},{"key":"2024121400015953900_bib81","doi-asserted-by":"crossref","first-page":"7114","DOI":"10.1038\/s41467-023-42796-0","article-title":"An FcRn-targeted mucosal vaccine against SARS-CoV-2 infection and transmission","volume":"14","author":"Li","year":"2023","journal-title":"Nat Commun"},{"key":"2024121400015953900_bib82","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s00281-009-0191-2","article-title":"Th17 cytokines and vaccine-induced immunity","volume":"32","author":"Lin","year":"2010","journal-title":"Semin Immunopathol"},{"key":"2024121400015953900_bib83","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1093\/infdis\/jiab496","article-title":"Reduced endometrial ascension and enhanced reinfection associated with immunoglobulin G antibodies to specific Chlamydia trachomatis proteins in women at risk for Chlamydia","volume":"225","author":"Liu","year":"2022","journal-title":"J Infect Dis"},{"key":"2024121400015953900_bib84","doi-asserted-by":"crossref","first-page":"5327","DOI":"10.1128\/IAI.02576-14","article-title":"Plasmid-encoded Pgp3 is a major virulence factor for Chlamydia muridarum to induce hydrosalpinx in mice","volume":"82","author":"Liu","year":"2014","journal-title":"Infect Immun"},{"key":"2024121400015953900_bib85","doi-asserted-by":"crossref","first-page":"530686","DOI":"10.3389\/fvets.2020.530686","article-title":"Capturing complex vaccine-immune-disease relationships for free-ranging koalas higher chlamydial loads are associated with less IL17 expression and more chlamydial disease","volume":"7","author":"Lizarraga","year":"2020","journal-title":"Front Vet Sci"},{"key":"2024121400015953900_bib86","doi-asserted-by":"crossref","first-page":"1057375","DOI":"10.3389\/fimmu.2022.1057375","article-title":"Multi-component prime-boost Chlamydia trachomatis vaccination regimes induce antibody and T cell responses and accelerate clearance of infection in a non-human primate model","volume":"13","author":"Lorenzen","year":"2022","journal-title":"Front Immunol"},{"key":"2024121400015953900_bib87","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/s13567-015-0241-9","article-title":"A review of the human vs. porcine female genital tract and associated immune system in the perspective of using minipigs as a model of human genital Chlamydia infection","volume":"46","author":"Lorenzen","year":"2015","journal-title":"Vet Res"},{"key":"2024121400015953900_bib88","doi-asserted-by":"crossref","first-page":"10542","DOI":"10.1128\/JVI.05441-11","article-title":"A neonatal Fc receptor-targeted mucosal vaccine strategy effectively induces HIV-1 antigen-specific immunity to genital infection","volume":"85","author":"Lu","year":"2011","journal-title":"J Virol"},{"key":"2024121400015953900_bib89","doi-asserted-by":"crossref","first-page":"R99","DOI":"10.1530\/REP-16-0561","article-title":"Male genital tract immune response against Chlamydia trachomatis infection","volume":"154","author":"Mackern-Oberti","year":"2017","journal-title":"Reproduction"},{"key":"2024121400015953900_bib90","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.vaccine.2016.11.040","article-title":"Immunogenicity and protective efficacy induced by self-amplifying mRNA vaccines encoding bacterial antigens","volume":"35","author":"Maruggi","year":"2017","journal-title":"Vaccine"},{"key":"2024121400015953900_bib91","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.vaccine.2019.10.047","article-title":"Type I IFN signalling is required for cationic adjuvant formulation (CAF)01-induced cellular immunity and mucosal priming","volume":"38","author":"McEntee","year":"2020","journal-title":"Vaccine"},{"key":"2024121400015953900_bib92","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1038\/nm1128","article-title":"Recombinant modified vaccinia virus Ankara expressing antigen 85A boosts BCG-primed and naturally acquired antimycobacterial immunity in humans","volume":"10","author":"McShane","year":"2004","journal-title":"Nat Med"},{"key":"2024121400015953900_bib93","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1158\/1078-0432.CCR-21-1963","article-title":"Phase I dose-escalation trial of MIW815 (ADU-S100), an intratumoral STING agonist, in patients with advanced\/metastatic solid tumors or lymphomas","volume":"28","author":"Meric-Bernstam","year":"2022","journal-title":"Clin Cancer Res"},{"key":"2024121400015953900_bib94","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1001\/jama.291.18.2229","article-title":"Prevalence of chlamydial and gonococcal infections among young adults in the United States","volume":"291","author":"Miller","year":"2004","journal-title":"JAMA"},{"key":"2024121400015953900_bib95","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/s41577-022-00746-9","article-title":"IL-17 and IL-17-producing cells in protection versus pathology","volume":"23","author":"Mills","year":"2023","journal-title":"Nat Rev Immunol"},{"key":"2024121400015953900_bib96","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1086\/377134","article-title":"Fc receptor-mediated antibody regulation of T cell immunity against intracellular pathogens","volume":"188","author":"Moore","year":"2003","journal-title":"J Infect Dis"},{"key":"2024121400015953900_bib97","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1093\/infdis\/jiq176","article-title":"Murine Chlamydia trachomatis genital infection is unaltered by depletion of CD4+ T cells and diminished adaptive immunity","volume":"203","author":"Morrison","year":"2011","journal-title":"J Infect Dis"},{"key":"2024121400015953900_bib98","doi-asserted-by":"crossref","first-page":"2870","DOI":"10.1128\/IAI.68.5.2870-2879.2000","article-title":"In situ analysis of the evolution of the primary immune response in murine Chlamydia trachomatis genital tract infection","volume":"68","author":"Morrison","year":"2000","journal-title":"Infect Immun"},{"key":"2024121400015953900_bib99","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.biotechadv.2017.03.005","article-title":"Biotechnology approaches to produce potent, self-adjuvanting antigen-adjuvant fusion protein subunit vaccines","volume":"35","author":"Moyle","year":"2017","journal-title":"Biotechnol Adv"},{"key":"2024121400015953900_bib100","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1128\/IAI.01280-06","article-title":"Intranasal vaccination with a secreted chlamydial protein enhances resolution of genital Chlamydia muridarum infection, protects against oviduct pathology, and is highly dependent upon endogenous gamma interferon production","volume":"75","author":"Murthy","year":"2007","journal-title":"Infect Immun"},{"key":"2024121400015953900_bib101","doi-asserted-by":"crossref","first-page":"2928","DOI":"10.1128\/IAI.05022-11","article-title":"Tumor necrosis factor alpha production from CD8+ T cells mediates oviduct pathological sequelae following primary genital Chlamydia muridarum infection","volume":"79","author":"Murthy","year":"2011","journal-title":"Infect Immun"},{"key":"2024121400015953900_bib102","doi-asserted-by":"crossref","first-page":"ftae008","DOI":"10.1093\/femspd\/ftae008","article-title":"Protective anti-chlamydial vaccine regimen-induced CD4+ T cell response mediates early inhibition of pathogenic CD8+ T cell response following genital challenge","volume":"82","author":"Murthy","year":"2024","journal-title":"Pathog Dis"},{"key":"2024121400015953900_bib103","doi-asserted-by":"crossref","first-page":"26129","DOI":"10.1074\/jbc.M605482200","article-title":"Sequential proteolytic processing of the capsular Caf1 antigen of Yersinia pestis for major histocompatibility complex class II-restricted presentation to T lymphocytes","volume":"281","author":"Musson","year":"2006","journal-title":"J Biol Chem"},{"key":"2024121400015953900_bib104","doi-asserted-by":"crossref","first-page":"3232","DOI":"10.1128\/IAI.00749-16","article-title":"IFNgamma is required for optimal antibody-mediated immunity against genital Chlamydia infection","volume":"84","author":"Naglak","year":"2016","journal-title":"Infect Immun"},{"key":"2024121400015953900_bib105","doi-asserted-by":"crossref","first-page":"e00409","DOI":"10.1128\/IAI.00409-17","article-title":"Neutrophils are Central to antibody-mediated protection against genital Chlamydia","volume":"85","author":"Naglak","year":"2017","journal-title":"Infect Immun"},{"key":"2024121400015953900_bib106","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1038\/nature08511","article-title":"CD8(+) T lymphocyte mobilization to virus-infected tissue requires CD4(+) T-cell help","volume":"462","author":"Nakanishi","year":"2009","journal-title":"Nature"},{"key":"2024121400015953900_bib107","doi-asserted-by":"crossref","first-page":"10658","DOI":"10.1073\/pnas.0504198102","article-title":"Chlamydial IFN-gamma immune evasion is linked to host infection tropism","volume":"102","author":"Nelson","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2024121400015953900_bib108","doi-asserted-by":"crossref","first-page":"e0143304","DOI":"10.1371\/journal.pone.0143304","article-title":"Global estimates of the prevalence and incidence of four curable sexually transmitted infections in 2012 based on systematic review and Global reporting","volume":"10","author":"Newman","year":"2015","journal-title":"PLoS One"},{"key":"2024121400015953900_bib109","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.4049\/jimmunol.2100297","article-title":"FcRn-targeted mucosal vaccination against Influenza virus infection","volume":"207","author":"Ochsner","year":"2021","journal-title":"J Immunol"},{"key":"2024121400015953900_bib110","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1128\/IAI.01118-10","article-title":"Toll-like receptor 2 activation by Chlamydia trachomatis is plasmid dependent, and plasmid-responsive chromosomal loci are coordinately regulated in response to glucose limitation by C. trachomatis but not by C. muridarum","volume":"79","author":"O'Connell","year":"2011","journal-title":"Infect Immun"},{"key":"2024121400015953900_bib111","doi-asserted-by":"crossref","first-page":"4027","DOI":"10.4049\/jimmunol.179.6.4027","article-title":"Plasmid-deficient Chlamydia muridarum fail to induce immune pathology and protect against oviduct disease","volume":"179","author":"O'Connell","year":"2007","journal-title":"J Immunol"},{"key":"2024121400015953900_bib112","doi-asserted-by":"crossref","first-page":"4602","DOI":"10.4049\/jimmunol.1001892","article-title":"The capacity to induce cross-presentation dictates the success of a TLR7 agonist-conjugate vaccine for eliciting cellular immunity","volume":"185","author":"Oh","year":"2010","journal-title":"J Immunol"},{"key":"2024121400015953900_bib113","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1093\/infdis\/jiv137","article-title":"Protection against Chlamydia trachomatis infection and upper genital tract pathological changes by vaccine-promoted neutralizing antibodies directed to the VD4 of the major outer membrane protein","volume":"212","author":"Olsen","year":"2015","journal-title":"J Infect Dis"},{"key":"2024121400015953900_bib114","doi-asserted-by":"crossref","first-page":"e10768","DOI":"10.1371\/journal.pone.0010768","article-title":"Protection against Chlamydia promoted by a subunit vaccine (CTH1) compared with a primary intranasal infection in a mouse genital challenge model","volume":"5","author":"Olsen","year":"2010","journal-title":"PLoS One"},{"key":"2024121400015953900_bib115","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/icb.2013.92","article-title":"Immunity against a Chlamydia infection and disease may be determined by a balance of IL-17 signaling","volume":"92","author":"O'Meara","year":"2014","journal-title":"Immunol Cell Biol"},{"key":"2024121400015953900_bib116","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1038\/mi.2015.125","article-title":"Induction of partial immunity in both males and females is sufficient to protect females against sexual transmission of Chlamydia","volume":"9","author":"O'Meara","year":"2016","journal-title":"Mucosal Immunol"},{"key":"2024121400015953900_bib117","doi-asserted-by":"crossref","first-page":"795048","DOI":"10.3389\/fimmu.2021.795048","article-title":"The cGAS-STING pathway a promising immunotherapy target","volume":"12","author":"Ou","year":"2021","journal-title":"Front Immunol"},{"key":"2024121400015953900_bib118","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1097\/OLQ.0b013e318285c6d2","article-title":"The estimated direct medical cost of selected sexually transmitted infections in the United States, 2008","volume":"40","author":"Owusu-Edusei","year":"2013","journal-title":"Sex Transm Dis"},{"key":"2024121400015953900_bib119","doi-asserted-by":"crossref","first-page":"5963","DOI":"10.1038\/s41467-023-41410-7","article-title":"A glycolipidated-liposomal peptide vaccine confers long-term mucosal protection against Streptococcus pyogenes via IL-17, macrophages and neutrophils","volume":"14","author":"Ozberk","year":"2023","journal-title":"Nat Commun"},{"key":"2024121400015953900_bib120","doi-asserted-by":"crossref","first-page":"8153","DOI":"10.1128\/IAI.73.12.8153-8160.2005","article-title":"Vaccination with the Chlamydia trachomatis major outer membrane protein can elicit an immune response as protective as that resulting from inoculation with live bacteria","volume":"73","author":"Pal","year":"2005","journal-title":"Infect Immun"},{"key":"2024121400015953900_bib121","doi-asserted-by":"crossref","first-page":"e00834","DOI":"10.1128\/IAI.00834-18","article-title":"Characterization of the horizontal and vertical sexual transmission of Chlamydia genital infections in a new mouse model","volume":"87","author":"Pal","year":"2019","journal-title":"Infect Immun"},{"key":"2024121400015953900_bib122","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1016\/j.vaccine.2017.02.020","article-title":"The cationic liposomal adjuvants CAF01 and CAF09 formulated with the major outer membrane protein elicit robust protection in mice against a Chlamydia muridarum respiratory challenge","volume":"35","author":"Pal","year":"2017","journal-title":"Vaccine"},{"key":"2024121400015953900_bib123","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1083\/jcb.200804023","article-title":"Cytopathicity of Chlamydia is largely reproduced by expression of a single chlamydial protease","volume":"182","author":"Paschen","year":"2008","journal-title":"J Cell Biol"},{"key":"2024121400015953900_bib124","doi-asserted-by":"crossref","first-page":"1018774","DOI":"10.3389\/fimmu.2022.1018774","article-title":"Efficacy of Pgp3 vaccination for Chlamydia urogenital tract infection depends on its native conformation","volume":"13","author":"Peng","year":"2022","journal-title":"Front Immunol"},{"key":"2024121400015953900_bib125","doi-asserted-by":"crossref","first-page":"3344","DOI":"10.4049\/jimmunol.158.7.3344","article-title":"Immunity to Chlamydia trachomatis is mediated by T helper 1 cells through IFN-gamma-dependent and -independent pathways","volume":"158","author":"Perry","year":"1997","journal-title":"JImmunol"},{"key":"2024121400015953900_bib126","doi-asserted-by":"crossref","first-page":"2702","DOI":"10.1016\/j.ymthe.2023.07.022","article-title":"Development of an mRNA-lipid nanoparticle vaccine against Lyme disease","volume":"31","author":"Pine","year":"2023","journal-title":"Mol Ther"},{"key":"2024121400015953900_bib127","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and efficacy of the BNT162b2 mRNA covid-19 vaccine","volume":"383","author":"Polack","year":"2020","journal-title":"N Engl J Med"},{"key":"2024121400015953900_bib128","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S1473-3099(20)30476-X","article-title":"Safety and immunogenicity of a two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in adults in Europe (EBOVAC2) a randomised, observer-blind, participant-blind, placebo-controlled, phase 2 trial","volume":"21","author":"Pollard","year":"2021","journal-title":"Lancet Infect Dis"},{"key":"2024121400015953900_bib129","doi-asserted-by":"crossref","first-page":"7289","DOI":"10.1016\/j.vaccine.2017.01.023","article-title":"Status of vaccine research and development of vaccines for Chlamydia trachomatis infection","volume":"37","author":"Poston","year":"2019","journal-title":"Vaccine"},{"key":"2024121400015953900_bib130","doi-asserted-by":"crossref","first-page":"e00143","DOI":"10.1128\/IAI.00143-18","article-title":"T cell-independent gamma interferon and B cells cooperate to prevent mortality associated with disseminated Chlamydia muridarum genital tract infection","volume":"86","author":"Poston","year":"2018","journal-title":"Infect Immun"},{"key":"2024121400015953900_bib131","doi-asserted-by":"crossref","first-page":"2845","DOI":"10.4049\/jimmunol.1700914","article-title":"A Chlamydia-specific TCR-transgenic mouse demonstrates Th1 polyfunctionality with enhanced effector function","volume":"199","author":"Poston","year":"2017","journal-title":"J Immunol"},{"key":"2024121400015953900_bib132","doi-asserted-by":"crossref","first-page":"e3506","DOI":"10.21769\/BioProtoc.3506","article-title":"Transcervical mouse infections with Chlamydia trachomatis and determination of bacterial burden","volume":"10","author":"Rajeeve","year":"2020","journal-title":"Bio-Protocol"},{"key":"2024121400015953900_bib133","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/s41586-018-0705-y","article-title":"Design of amidobenzimidazole STING receptor agonists with systemic activity","volume":"564","author":"Ramanjulu","year":"2018","journal-title":"Nature"},{"key":"2024121400015953900_bib134","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1093\/infdis\/jiw244","article-title":"Safety and high level efficacy of the combination malaria vaccine regimen of RTS,S\/AS01B with Chimpanzee Adenovirus 63 and modified vaccinia Ankara vectored vaccines expressing ME-TRAP","volume":"214","author":"Rampling","year":"2016","journal-title":"J Infect Dis"},{"key":"2024121400015953900_bib135","doi-asserted-by":"crossref","first-page":"3284","DOI":"10.1128\/IAI.00147-09","article-title":"Strain and virulence diversity in the mouse pathogen Chlamydia muridarum","volume":"77","author":"Ramsey","year":"2009","journal-title":"Infect Immun"},{"key":"2024121400015953900_bib136","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1086\/652399","article-title":"Protective immunity to chlamydial genital infection evidence from animal studies","volume":"201","author":"Rank","year":"2010","journal-title":"J Infect Dis"},{"key":"2024121400015953900_bib137","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1056\/NEJMoa0908492","article-title":"Investigators M-T vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand","volume":"361","author":"Rerks-Ngarm","year":"2009","journal-title":"N Engl J Med"},{"key":"2024121400015953900_bib138","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1089\/hum.2014.024","article-title":"Regression of human papillomavirus intraepithelial lesions is induced by MVA E2 therapeutic vaccine","volume":"25","author":"Rosales","year":"2014","journal-title":"Hum Gene Ther"},{"key":"2024121400015953900_bib139","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1093\/infdis\/jiv438","article-title":"Analysis of factors driving incident and ascending infection and the role of serum antibody in Chlamydia trachomatis genital tract infection","volume":"213","author":"Russell","year":"2016","journal-title":"J Infect Dis"},{"key":"2024121400015953900_bib140","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1093\/infdis\/jiw485","article-title":"Identification of Chlamydia trachomatis antigens recognized by T cells from highly exposed women who limit or resist genital tract infection","volume":"214","author":"Russell","year":"2016","journal-title":"J Infect Dis"},{"key":"2024121400015953900_bib141","doi-asserted-by":"crossref","first-page":"585","DOI":"10.7326\/M20-5306","article-title":"A double-blind, randomized, placebo-controlled phase 1 study of Ad26.ZIKV.001, an Ad26-vectored Anti-Zika Virus vaccine","volume":"174","author":"Salisch","year":"2021","journal-title":"Ann Intern Med"},{"key":"2024121400015953900_bib142","doi-asserted-by":"crossref","first-page":"2756","DOI":"10.4049\/jimmunol.0904013","article-title":"Cutting edge mincle is essential for recognition and adjuvanticity of the mycobacterial cord factor and its synthetic analog trehalose-dibehenate","volume":"184","author":"Schoenen","year":"2010","journal-title":"J Immunol"},{"key":"2024121400015953900_bib143","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1097\/MOP.0000000000000578","article-title":"The growing epidemic of sexually transmitted infections in adolescents a neglected population","volume":"30","author":"Shannon","year":"2018","journal-title":"Curr Opin Pediatr"},{"key":"2024121400015953900_bib144","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1095\/biolreprod.114.124180","article-title":"Chlamydia muridarum infection-induced destruction of male germ cells and sertoli cells is partially prevented by Chlamydia major outer membrane protein-specific immune CD4 cells","volume":"92","author":"Sobinoff","year":"2015","journal-title":"Biol Reprod"},{"key":"2024121400015953900_bib145","first-page":"699","article-title":"Trachoma vaccine field trials in the Gambia","volume":"67","author":"Sowa","year":"1969","journal-title":"J Hyg (Lond)"},{"key":"2024121400015953900_bib146","doi-asserted-by":"crossref","first-page":"S380","DOI":"10.1086\/513844","article-title":"Chlamydia trachomatis infections progress and problems","volume":"179","author":"Stamm","year":"1999","journal-title":"J Infect Dis"},{"key":"2024121400015953900_bib147","doi-asserted-by":"crossref","first-page":"aaa8205","DOI":"10.1126\/science.aaa8205","article-title":"VACCINES. A mucosal vaccine against Chlamydia trachomatis generates two waves of protective memory T cells","volume":"348","author":"Stary","year":"2015","journal-title":"Science"},{"key":"2024121400015953900_bib148","doi-asserted-by":"crossref","first-page":"5020","DOI":"10.1016\/j.vaccine.2009.05.008","article-title":"Protection against an intranasal challenge by vaccines formulated with native and recombinant preparations of the Chlamydia trachomatis major outer membrane protein","volume":"27","author":"Sun","year":"2009","journal-title":"Vaccine"},{"key":"2024121400015953900_bib149","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.intimp.2018.06.027","article-title":"Nasal vaccination with pneumococcal surface protein A in combination with cationic liposomes consisting of DOTAP and DC-chol confers antigen-mediated protective immunity against Streptococcus pneumoniae infections in mice","volume":"61","author":"Tada","year":"2018","journal-title":"Int Immunopharmacol"},{"key":"2024121400015953900_bib150","doi-asserted-by":"crossref","first-page":"e0120821","DOI":"10.1128\/AAC.01208-21","article-title":"First-in-Human evaluation of the safety, tolerability, and pharmacokinetics of SPR720, a novel oral bacterial DNA gyrase (GyrB) inhibitor for mycobacterial infections","volume":"65","author":"Talley","year":"2021","journal-title":"Antimicrob Agents Chemother"},{"key":"2024121400015953900_bib151","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S1473-3099(15)00362-X","article-title":"Use of ChAd3-EBO-Z Ebola virus vaccine in Malian and US adults, and boosting of Malian adults with MVA-BN-Filo a phase 1, single-blind, randomised trial, a phase 1b, open-label and double-blind, dose-escalation trial, and a nested, randomised, double-blind, placebo-controlled trial","volume":"16","author":"Tapia","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"2024121400015953900_bib152","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1002\/eji.201445132","article-title":"TLR9 and STING agonists synergistically induce innate and adaptive type-II IFN","volume":"45","author":"Temizoz","year":"2015","journal-title":"Eur J Immunol"},{"key":"2024121400015953900_bib153","doi-asserted-by":"crossref","first-page":"5529","DOI":"10.4049\/jimmunol.150.12.5529","article-title":"IFN-gamma-mediated antimicrobial response. Indoleamine 2,3-dioxygenase-deficient mutant host cells no longer inhibit intracellular Chlamydia spp. or toxoplasma growth","volume":"150","author":"Thomas","year":"1993","journal-title":"J Immunol"},{"key":"2024121400015953900_bib154","doi-asserted-by":"crossref","first-page":"919","DOI":"10.3389\/fmicb.2019.00919","article-title":"Alternatively activated macrophages are host cells for Chlamydia trachomatis and reverse anti-chlamydial classically activated macrophages","volume":"10","author":"Tietzel","year":"2019","journal-title":"Front Microbiol"},{"key":"2024121400015953900_bib155","doi-asserted-by":"crossref","first-page":"755","DOI":"10.3390\/vaccines9070755","article-title":"Induction of protection in mice against a Chlamydia muridarum respiratory challenge by a vaccine formulated with the major outer membrane protein in nanolipoprotein particles","volume":"9","author":"Tifrea","year":"2021","journal-title":"Vaccines (Basel)"},{"key":"2024121400015953900_bib156","doi-asserted-by":"crossref","first-page":"4623","DOI":"10.1016\/j.vaccine.2011.04.065","article-title":"Amphipols stabilize the Chlamydia major outer membrane protein and enhance its protective ability as a vaccine","volume":"29","author":"Tifrea","year":"2011","journal-title":"Vaccine"},{"key":"2024121400015953900_bib157","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1002\/1521-4141(200007)30:7<1939::AID-IMMU1939>3.0.CO;2-#","article-title":"Conjugation of protein to immunostimulatory DNA results in a rapid, long-lasting and potent induction of cell-mediated and humoral immunity","volume":"30","author":"Tighe","year":"2000","journal-title":"Eur J Immunol"},{"key":"2024121400015953900_bib158","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1016\/j.celrep.2018.04.003","article-title":"STING-activating adjuvants elicit a Th17 immune response and protect against mycobacterium tuberculosis infection","volume":"23","author":"Van\u00a0Dis","year":"2018","journal-title":"Cell Rep"},{"key":"2024121400015953900_bib159","doi-asserted-by":"crossref","first-page":"7098","DOI":"10.1016\/j.vaccine.2014.10.036","article-title":"A novel liposomal adjuvant system, CAF01, promotes long-lived mycobacterium tuberculosis-specific T-cell responses in human","volume":"32","author":"van\u00a0Dissel","year":"2014","journal-title":"Vaccine"},{"key":"2024121400015953900_bib160","doi-asserted-by":"crossref","first-page":"6730","DOI":"10.1073\/pnas.0900969106","article-title":"Ossendorp F antigen storage compartments in mature dendritic cells facilitate prolonged cytotoxic T lymphocyte cross-priming capacity","volume":"106","author":"van\u00a0Montfoort","year":"2009","journal-title":"P Natl Acad Sci U S A"},{"key":"2024121400015953900_bib161","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1016\/j.immuni.2022.10.014","article-title":"Innate immune mechanisms of mRNA vaccines","volume":"55","author":"Verbeke","year":"2022","journal-title":"Immunity"},{"key":"2024121400015953900_bib162","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1038\/icb.2015.74","article-title":"The contribution of Chlamydia-specific CD8(+) T cells to upper genital tract pathology","volume":"94","author":"Vlcek","year":"2016","journal-title":"Immunol Cell Biol"},{"key":"2024121400015953900_bib163","doi-asserted-by":"crossref","first-page":"4963","DOI":"10.1016\/j.vaccine.2019.07.019","article-title":"The STING activator c-di-AMP exerts superior adjuvant properties than the formulation poly(I:c)\/CpG after subcutaneous vaccination with soluble protein antigen or DEC-205-mediated antigen targeting to dendritic cells","volume":"37","author":"Volckmar","year":"2019","journal-title":"Vaccine"},{"key":"2024121400015953900_bib164","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s12977-016-0293-6","article-title":"New insights into the heterogeneity of Th17 subsets contributing to HIV-1 persistence during antiretroviral therapy","volume":"13","author":"Wacleche","year":"2016","journal-title":"Retrovirology"},{"key":"2024121400015953900_bib165","doi-asserted-by":"crossref","first-page":"e00630","DOI":"10.1128\/IAI.00630-17","article-title":"Nonpathogenic colonization with Chlamydia in the gastrointestinal tract as oral vaccination for inducing transmucosal protection","volume":"86","author":"Wang","year":"2018","journal-title":"Infect Immun"},{"key":"2024121400015953900_bib166","doi-asserted-by":"crossref","first-page":"3782","DOI":"10.1002\/(SICI)1521-4141(199911)29:11<3782::AID-IMMU3782>3.0.CO;2-B","article-title":"IFN-gamma knockout mice show Th2-associated delayed-type hypersensitivity and the inflammatory cells fail to localize and control chlamydial infection","volume":"29","author":"Wang","year":"1999","journal-title":"Eur J Immunol"},{"key":"2024121400015953900_bib167","doi-asserted-by":"crossref","first-page":"e0004323","DOI":"10.1128\/iai.00043-23","article-title":"Induction of transmucosal protection by oral vaccination with an attenuated Chlamydia","volume":"91","author":"Wang","year":"2023","journal-title":"Infect Immun"},{"key":"2024121400015953900_bib168","doi-asserted-by":"crossref","first-page":"e1006383","DOI":"10.1371\/journal.ppat.1006383","article-title":"Detection of a microbial metabolite by STING regulates inflammasome activation in response to Chlamydia trachomatis infection","volume":"13","author":"Webster","year":"2017","journal-title":"PLoS Pathog"},{"key":"2024121400015953900_bib169","doi-asserted-by":"crossref","first-page":"6267","DOI":"10.1038\/s41598-021-85709-1","article-title":"Site-specific antigen-adjuvant conjugation using cell-free protein synthesis enhances antigen presentation and CD8(+) T-cell response","volume":"11","author":"Weiss","year":"2021","journal-title":"Sci Rep"},{"key":"2024121400015953900_bib170","doi-asserted-by":"crossref","first-page":"569","DOI":"10.3389\/fimmu.2017.00569","article-title":"Simultaneous subcutaneous and intranasal administration of a CAF01-adjuvanted Chlamydia vaccine elicits elevated IgA and protective Th1\/Th17 responses in the genital tract","volume":"8","author":"Wern","year":"2017","journal-title":"Front Immunol"},{"key":"2024121400015953900_bib171","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1084\/jem.20081445","article-title":"Adjuvanticity of a synthetic cord factor analogue for subunit mycobacterium tuberculosis vaccination requires FcRgamma-Syk-Card9-dependent innate immune activation","volume":"206","author":"Werninghaus","year":"2009","journal-title":"J Exp Med"},{"key":"2024121400015953900_bib172","doi-asserted-by":"crossref","first-page":"3611","DOI":"10.4161\/hv.32253","article-title":"Serum and mucosal antibody responses to inactivated polio vaccine after sublingual immunization using a thermoresponsive gel delivery system","volume":"10","author":"White","year":"2014","journal-title":"Hum Vaccin Immunother"},{"key":"2024121400015953900_bib173","doi-asserted-by":"crossref","first-page":"15190","DOI":"10.1073\/pnas.0507484102","article-title":"HIV Gag protein conjugated to a toll-like receptor 7\/8 agonist improves the magnitude and quality of Th1 and CD8+ T cell responses in nonhuman primates","volume":"102","author":"Wille-Reece","year":"2005","journal-title":"P Natl Acad Sci U S A"},{"key":"2024121400015953900_bib174","doi-asserted-by":"crossref","first-page":"7676","DOI":"10.4049\/jimmunol.174.12.7676","article-title":"Immunization with HIV-1 Gag protein conjugated to a TLR7\/8 agonist results in the generation of HIV-1 Gag-specific Th1 and CD8+ T cell responses","volume":"174","author":"Wille-Reece","year":"2005","journal-title":"J Immunol"},{"key":"2024121400015953900_bib175","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1093\/infdis\/jiaa193","article-title":"Phase 1 safety and immunogenicity study of a Respiratory syncytial virus vaccine with an Adenovirus 26 vector encoding prefusion F (Ad26.RSV.preF) in adults aged &gt;\/=60 years","volume":"222","author":"Williams","year":"2020","journal-title":"J Infect Dis"},{"key":"2024121400015953900_bib176","first-page":"794","article-title":"Emerging and reemerging sexually transmitted infections. Reply","volume":"383","author":"Williamson","year":"2020","journal-title":"N Engl J Med"},{"key":"2024121400015953900_bib177","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/s41541-023-00760-5","article-title":"The advances of adjuvants in mRNA vaccines","volume":"8","author":"Xie","year":"2023","journal-title":"NPJ Vaccines"},{"key":"2024121400015953900_bib178","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1021\/acs.bioconjchem.7b00478","article-title":"Bioconjugation approaches to producing subunit vaccines composed of protein or peptide antigens and covalently attached toll-like receptor ligands","volume":"29","author":"Xu","year":"2018","journal-title":"Bioconjug Chem"},{"key":"2024121400015953900_bib179","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/nbt.1742","article-title":"Efficient mucosal vaccination mediated by the neonatal Fc receptor","volume":"29","author":"Ye","year":"2011","journal-title":"Nat Biotechnol"},{"key":"2024121400015953900_bib180","doi-asserted-by":"crossref","first-page":"6250","DOI":"10.1021\/bi047775v","article-title":"Characterization of the disulfide bonds and free cysteine residues of the Chlamydia trachomatis mouse pneumonitis major outer membrane protein","volume":"44","author":"Yen","year":"2005","journal-title":"Biochemistry"},{"key":"2024121400015953900_bib181","article-title":"Unique T cell signatures are associated with reduced Chlamydia trachomatis reinfection in a highly exposed cohort","author":"Yount","year":"2023","journal-title":"Biorxiv"},{"key":"2024121400015953900_bib182","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1128\/IAI.06338-11","article-title":"Chlamydia muridarum T cell antigens and adjuvants that induce protective immunity in mice","volume":"80","author":"Yu","year":"2012","journal-title":"Infect Immun"},{"key":"2024121400015953900_bib183","doi-asserted-by":"crossref","first-page":"4672","DOI":"10.1016\/j.vaccine.2014.06.002","article-title":"Evaluation of a multisubunit recombinant polymorphic membrane protein and major outer membrane protein T cell vaccine against Chlamydia muridarum genital infection in three strains of mice","volume":"32","author":"Yu","year":"2014","journal-title":"Vaccine"},{"key":"2024121400015953900_bib184","doi-asserted-by":"crossref","first-page":"3615","DOI":"10.4049\/jimmunol.1002952","article-title":"Immunization with live and dead Chlamydia muridarum induces different levels of protective immunity in a murine genital tract model correlation with MHC class II peptide presentation and multifunctional Th1 cells","volume":"186","author":"Yu","year":"2011","journal-title":"J Immunol"},{"key":"2024121400015953900_bib185","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1021\/acsinfecdis.2c00259","article-title":"Adjuvant-protein conjugate vaccine with built-In TLR7 agonist on S1 induces potent immunity against SARS-CoV-2 and variants of concern","volume":"8","author":"Zhang","year":"2022","journal-title":"ACS Infect Dis"},{"key":"2024121400015953900_bib186","doi-asserted-by":"crossref","first-page":"307","DOI":"10.3389\/fcimb.2018.00307","article-title":"Gene expression signatures can aid diagnosis of sexually transmitted infection-induced endometritis in women","volume":"8","author":"Zheng","year":"2018","journal-title":"Front Cell Infect Microbiol"},{"key":"2024121400015953900_bib187","doi-asserted-by":"crossref","first-page":"2941","DOI":"10.4049\/jimmunol.1701658","article-title":"Discovery of blood transcriptional endotypes in women with pelvic inflammatory disease","volume":"200","author":"Zheng","year":"2018","journal-title":"J Immunol"},{"key":"2024121400015953900_bib188","doi-asserted-by":"crossref","first-page":"e0047221","DOI":"10.1128\/iai.00472-21","article-title":"Chlamydia deficient in plasmid-encoded glycoprotein 3 (pGP3) as an attenuated live oral vaccine","volume":"90","author":"Zhou","year":"2022","journal-title":"Infect Immun"},{"key":"2024121400015953900_bib189","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1038\/nature10957","article-title":"Pathogen-induced human TH17 cells produce IFN-gamma or IL-10 and are regulated by IL-1beta","volume":"484","author":"Zielinski","year":"2012","journal-title":"Nature"},{"key":"2024121400015953900_bib190","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1186\/s40425-018-0455-2","article-title":"Novel TLR2-binding adjuvant induces enhanced T cell responses and tumor eradication","volume":"6","author":"Zom","year":"2018","journal-title":"J Immunotherapy Cancer"}],"container-title":["Pathogens and Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/femspd\/advance-article-pdf\/doi\/10.1093\/femspd\/ftae017\/58623996\/ftae017.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/femspd\/article-pdf\/doi\/10.1093\/femspd\/ftae017\/61155324\/ftae017.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/femspd\/article-pdf\/doi\/10.1093\/femspd\/ftae017\/61155324\/ftae017.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,14]],"date-time":"2024-12-14T00:02:39Z","timestamp":1734134559000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/femspd\/article\/doi\/10.1093\/femspd\/ftae017\/7718789"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"references-count":190,"URL":"https:\/\/doi.org\/10.1093\/femspd\/ftae017","relation":{},"ISSN":["2049-632X"],"issn-type":[{"value":"2049-632X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024]]},"published":{"date-parts":[[2024]]},"article-number":"ftae017"}}